immune system
• following subcutaneous challenge with FLUAD in 20 month old mice
|
• following subcutaneous challenge with FLUAD in 20 month old mice
|
• enhanced IgG isotypic switching in B cells following subcutaneous challenge with FLUAD (a trivalent inactivated influenza human vaccine that is also effective in rodents) in 20 month old mice
|
• slightly lower frequencies in the spleen of mice following subcutaneous challenge with FLUAD in 20 month old mice
|
• following subcutaneous challenge with FLUAD in 20 month old mice, mice exhibit a 2-fold increase in CD62L-CD44+ T effector cells with a decrease in CD62L+CD44- naive T cells compared with control mice
|
• 2-fold following subcutaneous challenge with FLUAD in 20 month old mice
|
• 2-fold increase in frequency of splenic CD4+ and CD8+ T cells following subcutaneous challenge with FLUAD in 20 month old mice
|
• 3-fold following subcutaneous challenge with FLUAD in 20 month old mice
|
• 2- to 3-fold increase in influenza-specific circulating IgGs following subcutaneous challenge with FLUAD in 20 month old mice
|
• in CD4+ T cells following subcutaneous challenge with FLUAD or antigen-specific vaccination and re-challenge in 20 month old mice
|
• in CD4+ T cells following subcutaneous challenge with FLUAD or antigen-specific vaccination and re-challenge in 20 month old mice
|
hematopoietic system
• following subcutaneous challenge with FLUAD in 20 month old mice
|
• following subcutaneous challenge with FLUAD in 20 month old mice
|
• enhanced IgG isotypic switching in B cells following subcutaneous challenge with FLUAD (a trivalent inactivated influenza human vaccine that is also effective in rodents) in 20 month old mice
|
• slightly lower frequencies in the spleen of mice following subcutaneous challenge with FLUAD in 20 month old mice
|
• following subcutaneous challenge with FLUAD in 20 month old mice, mice exhibit a 2-fold increase in CD62L-CD44+ T effector cells with a decrease in CD62L+CD44- naive T cells compared with control mice
|
• 2-fold following subcutaneous challenge with FLUAD in 20 month old mice
|
• 2-fold increase in frequency of splenic CD4+ and CD8+ T cells following subcutaneous challenge with FLUAD in 20 month old mice
|
• 5-fold following subcutaneous challenge with FLUAD in 20 month old mice
|
• 3-fold following subcutaneous challenge with FLUAD in 20 month old mice
|
• 2- to 3-fold increase in influenza-specific circulating IgGs following subcutaneous challenge with FLUAD in 20 month old mice
|
cellular
• following subcutaneous challenge with FLUAD in 20 month old mice
|
growth/size/body
• following subcutaneous challenge with FLUAD in 20 month old mice
|